James Saccaro Acquires 3,310 Shares of GE HealthCare Technologies (NASDAQ:GEHC) Stock

Key Points

• CFO James Saccaro purchased 3,310 shares of GE HealthCare (avg $60.60) for about $200,586, increasing his direct stake to 87,471 shares (a ~3.93% rise) as disclosed on an SEC Form 4.
• GE HealthCare missed Q1 EPS ($0.99 vs. $1.07 est.) despite a revenue beat of $5.13B, and management trimmed FY2026 guidance to $4.80–$5.00 EPS, triggering analyst price‑target cuts and softer sell‑side support.
• The company faces an investor litigation inquiry, introducing legal/regulatory risk that could amplify headline volatility for the stock.

GE HealthCare Technologies Inc. (NASDAQ:GEHC - Get Free Report) CFO James Saccaro acquired 3,310 shares of the stock in a transaction on Friday, May 1st. The shares were purchased at an average price of $60.60 per share, for a total transaction of $200,586.00. Following the transaction, the chief financial officer directly owned 87,471 shares in the company, valued at approximately $5,300,742.60. This trade represents a 3.93% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available at this link.

GE HealthCare Technologies Stock Performance

GEHC stock traded down $0.01 during trading hours on Friday, hitting $60.83. 5,887,437 shares of the stock were exchanged, compared to its average volume of 3,910,058. The firm has a market capitalization of $27.76 billion, a P/E ratio of 14.59, a P/E/G ratio of 1.34 and a beta of 1.17. GE HealthCare Technologies Inc. has a 12 month low of $58.75 and a 12 month high of $89.77. The company has a current ratio of 1.22, a quick ratio of 1.13 and a debt-to-equity ratio of 0.95. The company has a 50-day simple moving average of $73.28 and a two-hundred day simple moving average of $77.52.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.08). The company had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business's revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period last year, the company posted $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, analysts forecast that GE HealthCare Technologies Inc. will post 4.9 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be paid a $0.035 dividend. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies's dividend payout ratio (DPR) is 3.35%.

Analyst Ratings Changes

Several research firms recently weighed in on GEHC. Wall Street Zen lowered GE HealthCare Technologies from a "buy" rating to a "hold" rating in a research note on Saturday, March 21st. Stifel Nicolaus set a $80.00 price objective on GE HealthCare Technologies in a research note on Wednesday. Piper Sandler reduced their price objective on GE HealthCare Technologies from $96.00 to $88.00 and set an "overweight" rating on the stock in a research note on Friday, April 17th. Citigroup reduced their price objective on GE HealthCare Technologies from $80.00 to $65.00 and set a "neutral" rating on the stock in a research note on Thursday. Finally, BTIG Research reduced their price objective on GE HealthCare Technologies from $85.00 to $80.00 and set a "buy" rating on the stock in a research note on Wednesday. Eight investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, GE HealthCare Technologies currently has an average rating of "Hold" and an average price target of $80.67.

Hedge Funds Weigh In On GE HealthCare Technologies

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Western Wealth Management LLC raised its stake in GE HealthCare Technologies by 2.4% during the fourth quarter. Western Wealth Management LLC now owns 5,240 shares of the company's stock valued at $430,000 after buying an additional 125 shares during the last quarter. United Community Bank raised its stake in GE HealthCare Technologies by 10.2% during the fourth quarter. United Community Bank now owns 1,410 shares of the company's stock valued at $116,000 after buying an additional 130 shares during the last quarter. Parkside Financial Bank & Trust raised its stake in GE HealthCare Technologies by 3.9% during the fourth quarter. Parkside Financial Bank & Trust now owns 3,567 shares of the company's stock valued at $293,000 after buying an additional 134 shares during the last quarter. Thoma Capital Management LLC increased its holdings in shares of GE HealthCare Technologies by 1.4% in the 4th quarter. Thoma Capital Management LLC now owns 9,918 shares of the company's stock worth $814,000 after purchasing an additional 136 shares in the last quarter. Finally, Klingman & Associates LLC increased its holdings in shares of GE HealthCare Technologies by 4.0% in the 3rd quarter. Klingman & Associates LLC now owns 3,634 shares of the company's stock worth $273,000 after purchasing an additional 139 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies News Roundup

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Senior insiders buying shares — CFO James Saccaro purchased 3,310 shares (~$60.60 avg), increasing his stake; CEO Peter Arduini and director Frank R. Jimenez also made purchases. Insider buys often signal management confidence and can provide near‑term support. SEC Form 4: Saccaro
• Positive Sentiment: Unusual bullish options flow — investors bought ~19,196 call contracts (a ~448% jump vs. average), suggesting some traders are positioning for upside or event‑driven moves in the near term.
• Neutral Sentiment: Bullish coverage and idea pieces highlighting longer‑term upside potential and product strengths (diagnostics, imaging, PDx). These narratives can support conviction but are longer‑horizon and less likely to move the stock immediately. Yahoo/InsiderMonkey article
• Neutral Sentiment: Wells Fargo reset its price target to $75 (from $97) but kept an overweight rating — indicates remaining upside vs. current levels but more tempered near‑term expectations. AmericanBankingNews: Wells Fargo PT
• Negative Sentiment: Guidance cut and margin pressure — Q1 revenue beat ($5.13B) but EPS missed ($0.99 vs. $1.07 est.) and management trimmed FY26 EPS to $4.80–5.00, citing inflation, higher component/logistics costs and execution challenges; this is the core reason for recent selling pressure. Reuters: Guidance Cut
• Negative Sentiment: Analyst downgrades and price‑target cuts — Citi, JPMorgan and others trimmed targets (some to ~$65) and several desks shifted to neutral, reducing sell‑side near‑term support. AmericanBankingNews: Citi PT Cut
• Negative Sentiment: Investor litigation inquiry — a notice from Johnson Fistel about a potential claim involving executives introduces legal/regulatory risk and could amplify headline volatility. GlobeNewswire: Litigation Notice

About GE HealthCare Technologies

GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.